RTX Corporation shows strong EBITDA and free cash flow growth, with mid-single digit EBITDA growth. Read why I maintain my ...

Key Takeaways Roche announced plans to acquire Poseida Therapeutics for about $1 billion. Merck, AstraZeneca and Novartis ...

PTC Therapeutics faces significant risks with its key revenue sources, Translarna and Emflaza. Find out why I am sticking ...

In a report released today, Seth Sigman from Barclays maintained a Hold rating on Best Buy Co (BBY – Research Report), with a price target of ...

Shares of Poseida Therapeutics Inc. ($PSTX) surged over 200% on Tuesday, reaching levels not seen since August 2021, after ...

Buy or sell stocks: Despite market volatility, India's benchmark Nifty 50 broke its four-week losing streak, ending last week with a modest gain of approximately 0.51 per cent. However ...

Analysts expect HP Inc. HPQ to post quarterly earnings at 93 cents per share on revenue of $13.99 billion. The company will ...

Rivian Automotive ( RIVN 7.37%) has been an extremely volatile stock since its initial public offering in 2021. Yet volatility can often create incredible buying opportunities. After a recent ...

On Friday, the FDA approved BridgeBio Pharma's Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer ...

Here’s one reason investors should stick with stocks — despite warnings of a ‘lost decade’ ahead. U.S. stocks finished mostly higher on Wednesday, with the S&P 500 barely eking out a gain ...